Community Clinical Oncology Program

Actionable Insights Powered by AI

Incyte Discontinues Five Early-Stage Oncology Programs in Pipeline Refocus

Incyte, cancer pipeline, oncology programs, PD-L1 inhibitors, strategic review, R&D refocus